Study Protocol. In conducting and participating in the Study, Clinician Site and the Investigator shall comply with all applicable laws on data collection procedures and reimbursement procedures, protection of the personal data and moral rights of patients, especially including the secrecy of medical documentation archives and maintenance of records, as well as all other terms, conditions and obligations for clinician sites and investigators, including but not limited to follow the serious adverse event reporting process, as outlined in the Study protocol number RFB002A2406, attached hereto as Exhibit A, and any amendment thereof (the “Study Protocol”). In the event that the Study Protocol and this Agreement conflict, the Study Protocol shall prevail. 1.
Appears in 2 contracts
Sources: Participating Site Agreement, Participating Site Agreement